Identification of Novel and Selective GPR39 Receptor Antagonists for the Treatment of Acute Myocardial Ischemia

Documenti analoghi

• Discovery of Novel Aminopyrimidines as Selective EP2 Receptor Antagonists
  di: Isabelle Lyothier, et al.
  Pubblicazione: (2025)
• Structural Development of Androgen Receptor Antagonists Using Phenylferrocene Framework as a Hydrophobic Pharmacophore
  di: Kotaro Ochiai, et al.
  Pubblicazione: (2024)
• Lysophosphatidic Acid Receptor 1 (LPA1) Antagonists as Potential Migrastatics for Triple Negative Breast Cancer
  di: Wenjie Liu, et al.
  Pubblicazione: (2024)
• Development of New Benzo[ b ]Thiophene‐2‐Carboxamide Derivatives as Advanced Glycation End‐Products Receptor (RAGE) Antagonists
  di: Lisa Bonin, et al.
  Pubblicazione: (2025)
• Front Cover: Structural Development of Androgen Receptor Antagonists Using Phenylferrocene Framework as a Hydrophobic Pharmacophore (ChemMedChem 6/2024)
  di: Kotaro Ochiai, et al.
  Pubblicazione: (2024)